November 2021 Anthem Provider News - Missouri

Contents

Products & ProgramsCommercialNovember 1, 2021

Update regarding annual wellness visits for ACA-compliant health plans

PharmacyCommercialNovember 1, 2021

Important update on Botox for Anthem members

PharmacyCommercialNovember 1, 2021

Specialty pharmacy updates are available - November 2021

State & FederalMedicare AdvantageNovember 1, 2021

Electronic data interchange process

State & FederalMedicare AdvantageNovember 1, 2021

Clinical criteria updates

State & FederalMedicare AdvantageNovember 1, 2021

New York City Medicare Advantage announcement

State & FederalMedicare AdvantageNovember 1, 2021

Updates to AIM Specialty Health Cardiology Clinical Appropriateness Guidelines

State & FederalMedicare AdvantageNovember 1, 2021

Anthem offering Advance Medical Directives program for 2022

State & FederalMedicare AdvantageNovember 1, 2021

Keep up with Medicare News - November 2021

AdministrativeCommercialNovember 1, 2021

CME credits available in 2021 for a variety of clinical quality webinars - register now!


We recently offered a series of CME webinars on a variety of topics. If you missed any of them, you can still register for the recorded webinars and earn CME credits. The webinars offer best practices to overcoming barriers in achieving clinical quality goals, and attaining better patient outcomes. We also expect to offer more live CME webinars in the coming weeks.

 

  • Learn strategies to help you and your care team improve your performance across a range of clinical areas.
  • Apply the knowledge you gain from the webinars to improve your organization’s clinical quality.

 

Attendees will receive one CME credit upon answering required questions at the conclusion of each webinar.

 

Register here for our upcoming live and on-demand clinical quality webinars!

 

1391-1121-PN-CNT

AdministrativeCommercialNovember 1, 2021

Surprisingly easy ways to help patients quit smoking cigarettes

More than 42 million Americans reach for cigarettes regularly, but almost 70 percent of them say they want to quit. What gives? Maybe the traditional ways to quit smoking, such as going cold turkey or wearing a nicotine patch haven’t worked for them in the past. Thankfully, there are plenty of new ways to kick the smoking habit. Here are five approaches to share with patients who are trying to quit.

 

  1. Download a Quit Smoking App
    There are plenty of downloadable quit smoking apps ready to coach patients along the way. Many former smokers recommend the LIVESTRONG MyQuit Coach, a free app available on iTunes.

  2. Start a Quit Reward Fund
    According to a study from The New England Journal of Medicine, putting money on the line can help smokers quit. Researchers found 15.7% of people successfully quit for at least six months when they were offered an $800 reward. Patients can set aside their own money as a deposit that they get back when they successfully quit.

 

  1. Ask Human Resources about Resources
    Many employers offer smoking cessation programs, which offer cash rewards, savings on insurance or other perks for not taking a puff. According to the American Lung Association, up to 57% of their smoking cessation program participants reported quitting smoking by the end of the program. Freedom From Smoking®, offered by American Lung Association is an often recommended program.

 

  1. Quit Smoking with Meditation
    For many smokers, the act of lighting up is automatic. But a Yale University study found meditating and practicing mindfulness can cancel that relationship and slash cravings. Recommend a mobile app like Stop Smoking – Mindfulness Meditation App to Cessation Smoking Support.

 

  1. Consider Medication
    Over-the-counter nicotine patches are designed to lessen withdrawal symptoms and have been a go-to for decades. But if those haven’t worked prescription medications can reduce cravings or make smoking less enjoyable.

 

Measure Up! Medical Assistance with Smoking and Tobacco Use Cessation (MSC) HEDIS® measure looks at members 18 and older to assess different facets of providing medical assistance with smoking and tobacco use cessation:

  • Advising smokers and tobacco users to quit
  • Discussing cessation medications
  • Discussing cessation strategies

 

Measure adherence is determined by member response through the Consumer Assessment of Healthcare Providers and Systems (CAHPS) Health Plan Survey.

 

Sources: https://quitsmokingcommunity.org/the-6-best-quit-smoking-apps/ https://itunes.apple.com/us/app/livestrong-myquit-coach-dare/id383122255?mt=8&ign-mpt=uo%3D4http://www.nejm.org/doi/full/10.1056/NEJMoa1414293#t=articleDiscussionhttp://elischolar.library.yale.edu/cgi/viewcontent.cgi?article=1712&context=ymtdlhttps://itunes.apple.com/us/app/stop-smoking-mindfulness-meditation/id621443244?mt=8http://www.health.harvard.edu/blog/whats-best-way-quit-smoking-201607089935http://www.lung.org/support-and-community/corporate-wellness/help-employees-stop-smoking.html?referrer=https://www.google.com/

 

1407-1121-PN-CNT

AdministrativeCommercialNovember 1, 2021

Be Antibiotics Aware: Protect your patient



Each year, the CDC encourages healthcare professionals, patients, and families to learn more about antibiotics by promoting U.S. Antibiotic Awareness Week (USAAW). Highlighting the importance of improving antibiotic prescribing and use, USAAW brings these lifesaving drugs to the forefront.

 

With a focus on helping to fight antibiotic resistance, USAAW asks you to Be Antibiotic Aware1 and share this information with your patients:

  1. Antibiotics can save lives. When a patient needs antibiotics, the benefits outweigh the risks of side effects or antibiotic resistance.
  2. Antibiotics aren’t always the answe Everyone can help improve antibiotic prescribing and use.
  3. Antibiotics do not work on viruses, such as those that cause colds, flu, bronchitis, or runny noses.
  4. Antibiotics are only needed for treating infections caused by bacteria, but even some bacterial infections get better without antibiotics, including many sinus infections and some ear infections.
  5. Antibiotics will not make patient’s feel better if the illness is a virus. Respiratory viruses usually go away in a week or two without treatment.
  6. If antibiotics are needed, they should be taken exactly as prescribed. Provide information about potential side effects, including those that could result in treatment.
  7. Antibiotics are critical tools for treating life-threatening conditions.

 

Each year in the United States, more than 2.8 million infections occur from antibiotic-resistant bacteria. More than 35,000 people die as a result.

 

Measure up: Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB)

This HEDIS® measure looks at the percentage of members ages 3 months and older with a diagnosis of acute bronchitis/bronchiolitis that did not result in an antibiotic dispensing event. Visit the NCQA website for exceptions.

 

Description

CPT®/HCPCS/ICD-10

Acute Bronchitis

ICD-10: J20.3, J20.4, J20.5, J20.6, J20.7, J20.8, J20.9, J121.0, J21.1, J21.8, J21.9

Online assessments

CPT: 98970, 98971, 98972, 99422, 99423, 99457

HCPCS: G0071, G2010, G2012, G2061, G2062, G2063

Telephone visits

CPT: 98966, 98967, 98968, 99441, 99442, 99443

 

To learn more about antibiotic prescribing and use, visit www.cdc.gov/antibioticuse.

 

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

 

1CDC www.cdc.gov/antibiotic-use

 

1406-1121-PN-CNT

AdministrativeCommercialNovember 1, 2021

Reducing the burden of medical record review and improving health outcomes with ECDS reporting

The HEDIS® Electronic Clinical Data Systems (ECDS) reporting methodology encourages the exchange of the information needed to provide high-quality health-care services. 

 

The ECDS Reporting Standard provides a method to collect and report structured electronic clinical data for HEDIS quality measurement and improvement. 

 

Benefits to providers:

  • Reduced burden of medical record review for quality reporting
  • Improved health outcomes and care quality due to greater insights for more specific patient-centered care

 

ECDS reporting is part of the National Committee for Quality Assurance (NCQA)’s larger strategy to enable a Digital Quality System and is aligned with the industry’s move to digital measures. 

 

Click here to learn more about NCQA’s digital quality system and what is means to you and your practice.

 

ECDS Measures

The first publicly reported measure using the HEDIS® Electronic Clinical Data System (ECDS) reporting standard is the Prenatal Immunization Status (PRS) measure.  In 2022, NCQA will include the PRS measure in Health Plan Ratings for Medicaid and Commercial plans for measurement year 2021.

 

For HEDIS Measurement Year 2022, the following measures can be reported using ECDS: 

  • Childhood Immunization Status CIS-E*
  • Immunizations for Adolescents IMA-E*
  • Breast Cancer Screening BCS-E
  • Colorectal Cancer Screening COL-E
  • Follow-Up Care for Children Prescribed ADHD Medication ADD-E
  • Metabolic Monitoring for Children and Adolescents on Antipsychotics APM-E*
  • Depression Screening and Follow-Up for Adolescents and Adults DSF-E
  • Utilization of the PHQ-9 to Monitor Depression Symptoms for Adolescents and Adults DMS-E
  • Depression Remission or Response for Adolescents and Adults DRR-E
  • Unhealthy Alcohol Use Screening and Follow-Up ASF-E
  • Adult Immunization Status AIS-E
  • Prenatal Immunization Status PRS-E (Accreditation measure for 2021)
  • Prenatal Depression Screening and Follow-Up PND-E
  • Postpartum Depression Screening and Follow-Up PDS-E

*Indicates that this is the first year that the measure can be reported using ECDS

 

Of note, NCQA added the ECDS reporting method to three existing HEDIS measures: Breast Cancer ScreeningColorectal Cancer Screening and Follow-up Care for Children Prescribed ADHD Medication. Initially, the ECDS method will be optional which provides health plans an opportunity to report using the ECDS method while transitioning to ECDS only in the future.

 

Other sources:

HealthITgov: https://www.healthit.gov/topic/health-it-and-health-information-exchange-basics/health-information-exchange

 

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).


1392-1121-PN-CNT

AdministrativeCommercialNovember 1, 2021

Time to prepare for HEDIS medical record review

Each year, Anthem Blue Cross and Blue Shield (Anthem) performs a review of a sample of our members’ medical records as part of the HEDIS® quality study. HEDIS® is part of a nationally recognized quality improvement initiative and is used by the Centers for Medicare & Medicaid Services (CMS), the National Committee for Quality Assurance (NCQA) and several states to monitor the performance of managed care organizations.

 

For 2021, Anthem will begin requesting medical records in January 2022. No special authorization is needed for you to share member medical record information with us, since quality assessment and improvement activities is a routine part of healthcare operations.

 

HEDIS® review is time sensitive, so please submit the requested medical records within the timeframe indicated in the initial HEDIS® request document.

 

Ways to submit your records:

 

  • Remote EMR Access Service – New!
    As we published in the September edition of Provider News, we now offer the Remote EMR Access Service to providers to submit member medical record information to Anthem. If you are interested in more information, please contact us at Centralized_EMR_Team@anthem.com.

  • Upload to our secure portal
    Medical records can be uploaded to the Anthem secure portal using the instructions in the request document.

  • Fax
    Medical records can be faxed to Anthem using the instructions in the request document.

  • Mail
    Medical records can be mailed to Anthem using the instructions in the request document.

 

We appreciate the quality of care you provide to our members. Your assistance is crucial to ensuring our data is statistically valid, auditable and accurately reflects quality performance.

 

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

 

1382-1121-PN-CNT

AdministrativeCommercialNovember 1, 2021

Change in coverage for continuous glucose monitors for some fully insured groups

Effective January 1, 2022, continuous glucose monitors (CGMs) will no longer be covered under the medical benefit as durable medical equipment for certain Anthem Blue Cross and Blue Shield (Anthem) fully insured groups. For these members, CGMs will only be covered under their pharmacy benefit. This applies for both new prescriptions and refills.

 

We will notify affected members via mail. Members who need to transfer CGMs from their medical benefit to their pharmacy benefit will need a new prescription from their provider.

 

Note that some Anthem groups will retain their medical DME coverage for CGMs and these members will have the option of using either the medical or pharmacy benefit. Generally, members receive their CGMs faster when obtained using their pharmacy benefit, so we encourage the use of the pharmacy benefit.

 

If you have questions, please contact Provider Services.

 

1411-1121-PN-CNT

AdministrativeCommercialNovember 1, 2021

Include referring provider name and NPI on home infusion therapy and ambulatory infusion suite professional claims

In an ongoing effort to promote accurate claims processing and payment, Anthem Blue Cross and Blue Shield (Anthem) prefers the referring physician name and national provider identifier (NPI) to be included on professional home infusion therapy services claims in field 17 and 17a on CMS1500 claim forms.

 

Providers should report the referring physician information in accordance with the Anthem guidelines in the EDI Companion Guide for electronically submitted claims.

 

If you have questions regarding this process, please contact your local Network Manager.

 

1381-1121-PN-CNT

AdministrativeCommercialNovember 1, 2021

Blue High Performance Network name changing for 2022

Blue High Performance Network plans offer access to providers with a record of delivering high-quality, efficient care. BlueHPN® networks first went live January 1, 2021 in more than 50 cities across the country, including the Kansas City metro area. Since then, our national customer base has grown, and again this fall, major employers will offer plans with access to our high performance network for the 2022 benefit year.

 

Member ID cards and other plan material will feature one small change for 2022: BlueHPN is now a single word rather than two.

 

As a reminder, BlueHPN is a national network designed from our local market expertise, deep data and strong provider relationships, and aligned with local networks across the country. These local networks are connected to the national chassis to form a national BlueHPN network. In Missouri, Anthem Blue Cross and Blue Shield (Anthem) offers large group employers plans with access to the Blue HPN network, with the Blue Preferred Network serving as the Missouri HPN entry.

 

If you are not sure whether your practice is part of the Blue Preferred Network and therefore the BlueHPN, ask your office manager or business office, or contact your Anthem network representative. Updated BlueHPN participation will be displayed in provider profiles in our provider directory January 1, 2021.

 

As has been true this year, you may see patients accessing the Blue HPN/Blue Preferred Network through Exclusive Provider Organization (EPO) plans or HSA plans with an EPO network. Under these plans, out of network benefits are limited to emergency or urgent care. Members must select a primary care provider, but PCP referrals are not required for specialty care.

 

Large group BlueHPN health plans sold in Missouri have a plan prefix of H8R, but keep in mind that other prefixes may be part of HPN plan member IDs. For example, the sample ID card below is for a fictional member from Missouri enrolled in the national employer Blue High Performance Network plan, with an “H7S” prefix. The “Blue High Performance Network” logo and “BlueHPN” indicator in the suitcase icon are the most reliable indicators that a member is enrolled in an HPN plan.


 

1390-1121-PN-MO

AdministrativeCommercialNovember 1, 2021

Anthem Alliance EPO 2022 prior authorization list for Commercial accounts

The Anthem Alliance EPO 2022 prior authorization list has been updated effective January 1, 2022. Please reference the Blues & CDHP Products Prior Authorization List on the Prior Authorization webpage.

 

Providers should continue to verify member eligibility and benefits prior to rendering services.

 

Please note: This change is not applicable to the members enrolled in the Mercy Co-worker Plan as they have a customized prior authorization list. Providers should call the prior authorization number on the back of the member ID card.

 

1395-1121-PN-MO

AdministrativeCommercialNovember 1, 2021

Join Anthem in talking about racism and its impact on health, and earn continuing education credits!

Healthcare and mental healthcare professionals have a vital role in improving health and wellbeing in our communities by identifying and treating racial trauma and injustice experienced by the individuals we serve. At Anthem Blue Cross and Blue Shield (Anthem), we are committed to addressing racism in our society through open discussions about trauma, injustice, and inequality. These conversations are critical to improving the wellbeing of all Americans and the communities in which we live and serve.

 

We can impact the injustice of racism together.

Anthem has partnered with Motivo*, the first HIPAA-compliant digital platform that connects mental health therapists and clinical supervisors, to engage providers and associates in conversations on racial injustice, trauma, and inequality. Together, we are continuing to evolve the conversation and digging deeper on a quarterly basis to keep the dialogue going.

 

Our racial equity forums focus on:

  • Exploring how racism impacts health outcomes.
  • Discussing how to identify racism in your practice and how to be an ally to your patients.
  • Recognizing implicit bias (we all have it!) and how it affects the care provided to your patients.
  • Understanding the impact of prolonged exposure to racism on people of .
  • Providing you with actionable resources to recognize and reduce racism that may exist in your practice.

 

Since October 2020, Anthem has sponsored four virtual forums:

 

Please register the date for the next forum: 

 

Equity, COVID, and holidays: Coping with grief
December 8, 2021
4:00-5:30 p.m. ET
 

Continuing education credits available for those who sign up and participate!

 

The first step in doing your part to addressing racism is to recognize that it exists.

These conversations may feel uncomfortable at first, and that’s okay – this is how we will make progress together in creating a more just and equitable society.

 

*Motivo is an independent company providing a virtual forum on behalf of Anthem.

 

1403-1121-PN-CNT

Digital SolutionsCommercialNovember 1, 2021

EnrollSafe is available: Our new electronic funds transfer enrollment portal for Anthem providers

EnrollSafe is now available as the electronic funds transfer (EFT) enrollment portal for Anthem Blue Cross and Blue Shield (Anthem) providers. Effective November 1, 2021, CAQH Enrollhub is no longer offering EFT enrollment to new users.

 

CAQH Enrollhub is the only CAQH tool being decommissioned.  All other CAQH tools are not impacted.

 

Benefits of EFT

 

Electronic funds transfer makes the payment process more convenient and easier to reconcile your direct deposits. EFT is also much faster. You’ll receive your payments up to seven days sooner than through the paper check method.

 

EnrollSafe:  Secure and available 24-hours a day

 

Beginning November 1, 2021, if you need to change an EFT enrollment previously submitted through CAQH, or enroll a new bank account for EFT, visit the EnrollSafe portal at https://enrollsafe.payeehub.org and select “Register.” Once you have completed registration, you’ll be directed through the EnrollSafe secure portal to the enrollment page. There, you’ll provide the required information to receive direct payment deposits. There is no fee to register for EFT via EnrollSafe.

 

Already enrolled in EFT through CAQH Enrollhub?

 

Please note if you’re already enrolled in EFT through CAQH Enrollhub, no action is needed. Your EFT enrollment information is not changing as a result of the new enrollment hub.

 

If you ever have changes to make to your bank account, use EnrollSafe going forward to update your EFT bank account information.

 

Electronic remittance advice (ERA) makes reconciling your EFT payments easy and paper-free

 

Now that you are enrolled in EFT, using the digital ERA is the very best way to reconcile your deposits – securely and efficiently. You’ll be issued a trace number with your EFT deposit that matches up with your ERA on Availity.

 

You can retrieve your ERAs directly from Availity. Simply log onto Availity and select Claims and Payments > Send and Receive EDI Files > Received Files folder. When using a clearinghouse or billing service, they will supply the 835 ERA for you. You also have the option to view or download a copy of the Remittance Advice under Payer Spaces > Remittance Inquiry tool.

 

Need further help?  EFT and ERA registration and contact information

 

Type of transaction:

How to register, update, or cancel:

For registration related questions, contact:

To resolve issues after registration, contact:

EFT only

Use EnrollSafe

EnrollSafe help desk at

877-882-0384

 

Available Monday through Friday 9 a.m. to 8 p.m. ET, except public and/or bank holidays.

 

E-mail: Support@payeehub.org

EnrollSafe help desk at

877-882-0384

 

Available Monday through Friday 9 a.m. to 8 p.m. ET, except public and/or bank holidays.

 

E-mail:

Support@payeehub.org

ERA (835) only

Use Availity

Availity Support

800-282-4548

Availity Support at
800-282-4548

 

NOTE: Providers should allow up to 10 business days for ERA enrollment processing.

 

1399-1121-PN-CNT

Digital SolutionsCommercialNovember 1, 2021

Against medical advice (AMA) discharge physician tracking tool

Anthem Blue Cross and Blue Shield (Anthem) is pleased to announce a new provider tool to assist physicians in tracking patients that are discharged from the hospital against medical advice (AMA).

 

This new tool, available through Anthem’s online Availity provider portal, will allow physicians to sign up for admission discharge transfer (ADT) alerts as well as other useful alerts. Once the report is accessed, the discharge type field is where an against medical advice (AMA) event will be identified. This will allow the primary care physician to reach out to the patient and schedule any follow up care as soon as possible.

 

Anthem encourages the use of this new tool as well as the other reports available. If you are interested in learning more and or obtaining additional information, please contact your assigned Provider Experience representative or visit us at anthem.com/provider/contact-us to view additional contact options.

 

1374-1121-PN-CNT

Reimbursement PoliciesCommercialNovember 1, 2021

Clarification to reimbursement policy updates: Modifier Rules and Guidelines for Reporting Timed Units for Physical Medicine and Rehabilitation - professional

In the January edition of Provider News, we announced updates to the following reimbursement policies:
  • Modifier Rules – professional
  • Guidelines for Reporting Timed Units for Physical Medicine and Rehabilitation – professional

 

For clarification, these modifier updates align with the codes the Centers for Medicare & Medicaid Services (CMS) has designated as “always therapy” services, and require GN, GO or GP modifiers for physical therapy, occupational therapy, or speech-language pathology services when billed on a professional claim.

 

1401-1121-PN-CNT

Products & ProgramsCommercialNovember 1, 2021

Update regarding annual wellness visits for ACA-compliant health plans

Anthem Blue Cross and Blue Shield (Anthem) covers annual wellness visits and well-woman visits at 100% with no member cost-sharing when provided by in-network providers for members that have ACA-compliant plans. Beginning January 1, 2022, Anthem will encourage some ACA-compliant individual and small group plan members to schedule annual wellness visits or well-woman visits with their physician within the first 90 days of the plan renewal.

 

Some providers currently require patients to schedule wellness visits or well-woman visits at least one year past their most recent visit. This practice helps ensure a patient does not exceed more than one wellness visit per calendar year. Beginning January 1, 2022, providers can perform the annual wellness visit or well-woman visit for these members, even if it has been less than one year since the last wellness visit. The claim for the wellness visit or well-woman visit will be processed as a preventive care service covered at 100% as long as its billed accordingly. 

 

Please note, this benefit may not apply to all health plans. Providers should continue to verify eligibility and benefits for all members prior to providing services or receiving member copayments, deductibles, or coinsurance.

 

1380-1121-PN-CNT

 

PharmacyCommercialNovember 1, 2021

Important update on Botox for Anthem members

Effective January 1, 2022, CVS Specialty Pharmacy and IngenioRx Specialty Pharmacy will no longer distribute the brand name drug Botox®. However, Botox will still be available to Anthem Blue Cross and Blue Shield (Anthem) members through other vendors.

 

Please note:

  • This is not a change in member benefits. This is a change in the Botox vendor only.
  • If the member is not using CVS Specialty Pharmacy to obtain Botox, no action is needed.
  • This change will not affect any other IngenioRx Specialty Pharmacy coverage.

 

Medical specialty pharmacy benefits

 

Our members who currently obtain Botox through CVS Specialty Pharmacy using their medical specialty pharmacy benefits must move this prescription by January 1, 2022. Here are the options:

 

  • Providers can to purchase Botox for their patients, then supply it Anthem Providers would then bill Anthem for the drug and administration of the drug. This will require a new prior authorization to notify Anthem of this change.

 

  • If the Anthem member’s pharmacy benefit manager is IngenioRx, providers can transition the Botox prescription to receive the drug using their pharmacy benefits. Transferring the coverage will require a new prescription and new prior authorization for IngenioRx.

 

For questions regarding a member’s medical specialty pharmacy benefits, call Provider Services using the information on the back of the member’s ID card.

 

Pharmacy benefits manager benefits

 

Effective January 1, 2022, members who currently obtain Botox through IngenioRx Specialty Pharmacy using their pharmacy benefits must move this prescription from IngenioRx Specialty Pharmacy to another in-network specialty pharmacy that distributes Botox. If there are refills still available on the current prescription, members can transfer it to the new pharmacy. If not, members will need a new prescription.

 

For questions regarding a member’s pharmacy benefits, call Pharmacy Member Services using the information on the back of the member’s ID card.

 

1383-1121-PN-CNT

PharmacyCommercialNovember 1, 2021

Specialty pharmacy updates are available - November 2021

Excerpt and top of article:

IN:

*Change to Prior Authorization Requirements

OH:

*Notice of Material Amendment/Change to Contract (MAC)

WI:

*Material Adverse Change (MAC)

 

Specialty pharmacy updates for Anthem Blue Cross and Blue Shield (Anthem) are listed below.

 

Prior authorization clinical review of non-oncology use of specialty pharmacy drugs is managed by Anthem’s medical specialty drug review team. Review of specialty pharmacy drugs for oncology use is managed by AIM Specialty Health® (AIM), a separate company.

 

Please note that inclusion of National Drug Code (NDC) code on your claim will help expedite claim processing of drugs billed with a Not Otherwise Classified (NOC) code.

 

Prior authorization updates

 

Effective for dates of service on and after February 1, 2022, the following specialty pharmacy codes from current or new clinical criteria documents will be included in our prior authorization review process.

 

Access our Clinical Criteria to view the complete information for these prior authorization updates.

 

Clinical Criteria

HCPCS or CPT Code(s)

Drug

ING-CC-0096**

J3590

Rylaze

ING-CC-0167**

Q5119

Ruxience

ING-CC-0167**

Q5115

Truxima

ING-CC-0202

J3490

J3590

Saphnelo

ING-CC-0203

J3490

J3590

Ryplazim

* Non-oncology use is managed by the medical specialty drug review team.

** Oncology use is managed by AIM.

 

Note: Prior authorization requests for certain medications may require additional documentation to determine medical necessity.

 

Step therapy updates

 

Effective for dates of service on and after February 1, 2022, the following specialty pharmacy codes from current or new clinical criteria documents will be included in our existing specialty pharmacy medical step therapy review process. 

 

Clinical Criteria

Status

HCPCS or CPT Code(s)

Drug

ING-CC-0075*

Preferred

J9312

Rituxan

Q5123

Riabni

Non-preferred

Q5119

Ruxience

Q5115

Truxima

ING-CC-0167**

Preferred

J9312

Rituxan

Q5123

Riabni

Non-preferred

Q5119

Ruxience

Q5115

Truxima

* Non-oncology use is managed by the medical specialty drug review team.

** Oncology use is managed by AIM.

 

Access our Clinical Criteria to view the complete information for these step therapy updates.

 

Quantity limit updates

 

Effective for dates of service on and after February 1, 2022, the following specialty pharmacy codes from current or new clinical criteria documents will be included in our quantity limit review process.

 

Access our Clinical Criteria to view the complete information for these quantity limit updates.

 

Clinical Criteria

HCPCS or CPT Code(s)

Drug

ING-CC-0081

J0584

Crysvita

ING-CC-0202

J3490

J3590

Saphnelo

 

1389-1121-PN-CNT

State & FederalMedicare AdvantageNovember 1, 2021

Electronic data interchange process

Availity* serves as our electronic data interchange (EDI) partner for all electronic data and transactions. The Availity EDI processing generates response files for each submitted electronic file and delivers them to the submitter’s Availity mailbox. It is important to review these responses to understand where your claims are in the process.

 

Electronic file submitter

If your organization uses a clearinghouse or vendor, they have an Availity mailbox to submit clients’ files. Availity delivers the responses for claims to the same mailbox, and the clearinghouse or vendor is responsible for returning the results to their clients and resubmitting any files rejected for formatting, interchange, or transaction set errors. The submitter in this scenario is the clearinghouse or vendor.

If your organization uses a practice management software, an Availity mailbox is set up during initial registration for your electronic file submissions. The submitter is your organization and is responsible for analyzing the responses to verify there are not any file errors or claim rejections that require correction and resubmission within timely filing guidelines.

 

Availity electronic file process

  • Submit electronic file to Availity — Availity validates for file format and returns file acknowledgments to the submitter’s Availity mailbox. If there are any edits at this point, the entire electronic file will not advance and will require resubmission within timely filing guidelines.
  • HIPAA and payer specific edits — The electronic file moves to the next phase, which is HIPAA and business editing. Examples include:
    • Valid subscriber ID for the date of service
    • Billing and coding validation
      If an error occurs at this point, the individual claims with the errors must be corrected, resubmitted as an original claim and do not advance. The claims that do not have an edit will then route to the adjudication systems for second-level edit validation.
  • Anthem payer receives electronic file from Availity — For the Medicare line of business, there is a second level of editing.

 

Edits for this second level return the Delayed Payer Report (DPR). Only claims that pass will advance for adjudication and will be displayed using Availity claim status, electronic claim status transactions, Availity remittance inquiry, 835 electronic remittance advice, and paper Explanation of Payment. If there are edits, the claim requires resubmission within timely filing guidelines.

 

Electronic responses

 

File acknowledgment — Indicates whether we receive an electronic file in the correct format and acceptance by Availity.

  • Action required — If any errors occur at this stage, the submitter will need to correct and resubmit the entire electronic file to Availity.

 

Immediate Batch Response (IBR) — This report acknowledges accepted claims and identifies claim edits due to HIPAA and business edits. The report also includes claim counts and charges for the electronic file. Availity creates this file prior to routing accepted claims to the adjudication systems.

  • Action required for claims with edits: Rejected claims require resubmission within timely filing guidelines and will not advance to the adjudication system that would display Availity claim status, electronic claim status transactions, Availity remittance inquiry, 835 electronic remittance advice, and paper Explanation of Payment. Not applicable to denied claims.

 

Delayed Payer Report (DPR) — This report is currently only returned for the Medicare line of business and contains second-level editing from the adjudication system after Availity has routed claims that passed on the IBR report.

  • Action required for claims with edits: Rejected claims would need to be resubmitted and will not display on Availity claim status, electronic claim status transactions, Availity remittance inquiry, 835 electronic remittance advice and paper Explanation of Payment.

 

What if I need assistance?

If you have questions about this communication or need assistance with any other item, contact your local Provider Experience representative or call the Provider Services on the back of patient’s member ID card, or Availity Client Services with any questions at 800-AVAILITY (282-4548).

 

* Availity, LLC is an independent company providing administrative support services on behalf of Anthem Blue Cross and Blue Shield.

 

ABSCRNU-0237-21

State & FederalMedicare AdvantageNovember 1, 2021

Clinical criteria updates

On August 21, 2020, November 20, 2020, and June 24, 2021, the Pharmacy and Therapeutics (P&T) Committee approved the following Clinical Criteria applicable to the medical drug benefit for Anthem Blue Cross and Blue Shield. These policies were developed, revised, or reviewed to support clinical coding edits.

 

Visit Clinical Criteria to search for specific policies. For questions or additional information, use this email.

 

Please see the explanation/definition for each category of Clinical Criteria below:

  • New: newly published criteria
  • Revised: addition or removal of medical necessity requirements, new document number
  • Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive

 

Please share this notice with other members of your practice and office staff.

 

Please note: The Clinical Criteria listed below applies only to the medical drug benefits contained within the member’s medical policy. This does not apply to pharmacy services.

 

Effective date

Document number

Clinical Criteria title

New or revised

November 1, 2021

*ING-CC-0201

Rybrevant (amivantamab-vmjm)

New

November 1, 2021

*ING-CC-0042

Monoclonal Antibodies to Interleukin-17

Revised

November 1, 2021

*ING-CC-0050

Monoclonal Antibodies to Interleukin-23

Revised

November 1, 2021

ING-CC-0125

Opdivo (nivolumab)

Revised

November 1, 2021

ING-CC-0124

Keytruda (pembrolizumab)

Revised

November 1, 2021

*ING-CC-0102

GnRH Analogs for Oncologic Indications

Revised

November 1, 2021

ING-CC-0076

Nulojix (belatacept)

Revised

November 1, 2021

*ING-CC-0077

Palynziq (pegvaliase-pqpz)

Revised

November 1, 2021

ING-CC-0067

Prostacyclin Infusion and Inhalation Therapy

Revised

November 1, 2021

ING-CC-0194

Cabenuva (cabotegravir extended-release; rilpivirine extended-release) Injection

Revised

 

ABSCRNU-0261-21

State & FederalMedicare AdvantageNovember 1, 2021

New York City Medicare Advantage announcement

The City of New York has awarded their group retiree business to the Retiree Health Alliance, an alliance between Empire BlueCross BlueShield (Empire) and EmblemHealth. Effective January 1, 2022, approximately 240,000 Medicare-eligible City of New York retirees across the United States will transition to Retiree Health Alliance’s NYC Medicare Advantage Plus plan.

 

The NYC Medicare Advantage Plus plan is a Medicare Advantage PPO plan that allows retirees to receive services from both in-network and out-of-network providers. Out-of-network providers must be eligible to receive Medicare payments to provide care to NYC retirees. Under this new plan, City of New York retirees will have no difference in cost share for both in-network and out-of-network services. NYC Medicare Advantage Plus offers the same hospital and medical benefits covered by original Medicare as well as additional benefits original Medicare does not provide, such as an annual routine physical exam, hearing, health and fitness tracker, LiveHealth Online,* and SilverSneakers.*

 

Retirees enrolled in NYC Medicare Advantage Plus will have access to BlueCross BlueShield Medicare Advantage PPO Network Sharing effective January 1, 2022. Recently, you may have received calls from City of New York retirees inquiring if you are participating or if you accept NYC Medicare Advantage Plus. Retirees may also refer to the new plan as Medicare Advantage Plus or the Alliance. 

 

Currently, City of New York retiree claims are processed by Medicare as primary and then by Empire for facility services or EmblemHealth for professional services as supplemental coverage under the General Health Insurance/Empire Senior Care plan.

 

Beginning January 1, 2022, under the NYC Medicare Advantage Plus plan, providers will change billing processes as follows:

  • Providers should submit all claims (facility, professional, and ancillary) to your local Blue plan.
    • Providers should not transmit any claims to original Medicare.
    • Claims can be submitted electronically or by paper submission (UB-04 or CMS-1500 form) to your local Blue plan.

 

For additional information, review the NYC Medicare Advantage FAQ at https://www.anthem.com/da/inline/pdf/abscare-1134-21.pdf.

 

* Availity, LLC is an independent company providing administrative support services on behalf of Empire BlueCross BlueShield. LiveHealth Online is an independent company providing online doctor visits on behalf of Empire BlueCross BlueShield. SilverSneakers is an independent company providing fitness management on behalf of Empire BlueCross BlueShield.

 

ABSCRNU-0278-21

State & FederalMedicare AdvantageNovember 1, 2021

Updates to AIM Specialty Health Cardiology Clinical Appropriateness Guidelines

Effective for dates of service on and after March 13, 2022, the following updates will apply to the AIM Specialty Health®* Diagnostic Coronary Angiography and Percutaneous Coronary Intervention Clinical Appropriateness Guidelines. As part of the AIM guideline annual review process, these updates are focused on advancing efforts to drive clinically appropriate, safe, and affordable healthcare services.

 

Diagnostic coronary angiography:

  • Removed indications for asymptomatic patients (in alignment with the ischemia trial)
  • Facilitated coronary angiography with a view to intervention in non-culprit vessels following
  • ST-segment elevation myocardial infarction (STEMI), in alignment with the complete trial
  • For patients undergoing preoperative evaluation for transcatheter aortic valve replacement (TAVR) or other valve surgery, aligned criteria with the updated American College of Cardiology (ACC)/American Heart Association (AHA) guideline for the management of patients with valvular heart disease

 

Percutaneous coronary intervention:

  • Revised criteria such that, for some cohorts, only those patients with persistent unacceptable symptoms and moderate or severe stress test abnormalities can proceed to revascularization (in alignment with the ischemia trial)
  • For non-left main percutaneous coronary intervention (PCI), expanded use to non-culprit vessels in patients following STEMI, and restricted use to those with moderate or severe stress test abnormalities who have failed medical therapy
  • Left main PCI limited to situations where coronary artery bypass grafting (CABG) is contraindicated or refused (in alignment with noble and excel trials)
  • Clarified requirements for patients who have undergone CABG: at least 70% luminal narrowing qualifies as stenosis, symptomatic ventricular tachycardia is considered an ischemic symptom, and instant wave-free ratio fractional flow reserve (iFR) is considered in noninvasive testing
  • Removed requirement to calculate syntax score for patients scheduled to undergo renal transplantation
  • For patients scheduled for percutaneous valvular procedures (e.g., TAVR/TAVI or mitral valve repair), added clarification that PCI should only be attempted for complex triple vessel disease when CABG is not an option

 

As a reminder, ordering and servicing providers may submit prior authorization requests to AIM in one of several ways:

  • AIM ProviderPortalSM at providerportal.com
    • Online access is available 24/7 to process orders in real-time, and is the fastest and most convenient way to request authorization.
  • Availity Portal at availity.com
  • AIM Contact Center toll-free number: 800-714-0040, Monday through Friday, 8 a.m. to 8 p.m. ET

 

What if I need assistance?

For questions related to guidelines, please contact AIM via email at aim.guidelines@aimspecialtyhealth.com. Additionally, you may access and download a copy of the current and upcoming guidelines online.

 

ABSCRNU-0272-21

State & FederalMedicare AdvantageNovember 1, 2021

Anthem offering Advance Medical Directives program for 2022

In 2022, Anthem Blue Cross and Blue Shield (Anthem) will be providing members with a new tool to develop an advance medical directive for many of its DSNP Medicare Advantage plans. Anthem has partnered with MyDirectives,* a leader in the industry for electronic advance directives. Information on the service will be provided to members via their Annual Notice of Change (ANOC), Evidence of Coverage (EOC), and Benefit Summaries.

 

To get started with the Advance Directives program, members will visit the Anthem member website and under the Benefits tab access a link for the Advance Directives program. Selecting this link will take the member to MyDirectives, where they can create a MyDirectives account or link an account if they already use MyDirectives.

 

MyDirectives has an easy-to-use guide that takes members through a series of questions around their care preferences, establishing of healthcare agents (medical powers of attorney), sharing of information, and more. If they already have a written advance directive, the software allows members to upload copies of their current directive, making it easier to store and share when necessary.

 

Physicians and hospitals can access a member’s advance directive via healthcare exchanges such as eHealth Exchange, Carequality, and CommonWell Health Alliance.

 

The benefit and associated links will be live as of the new plan year. We encourage you to speak to your members about the value of an establishing an advance directive and support members as they go through the process.

 

* MyDirectives is an independent company providing electronic advance directives services on behalf of Anthem Blue Cross and Blue Shield.

 

ABSCRNU-0269-21